PRAK-03202: A triple antigen virus-like particle vaccine candidate against SARS CoV-2. (PubMed, Heliyon) - Oct 12, 2021 - "Peripheral blood mononuclear cells from convalescent patients showed lymphocyte proliferation and elevated interferon levels suggestive of epitope conservation and induction of T helper 1-biased cellular immune response when exposed to PRAK-03202. These data support further clinical development and testing of PRAK-03202 for use in humans."
Journal • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases
|